Witold Kędzia
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Witold Kędzia has a total of 45 co-authors. Here are the top co-authors by number of shared publications:
- Grażyna Jarząbek-Bielecka
Klinika Ginekologii Uniwersytetu Medycznego w Poznaniu/Gynecology Clinic, Poznan University of Medical Sciences, Poland
9 shared publications - Magdalena Pisarska-Krawczyk
Department of Nursing, The President Stanislaw Wojciechowski Calisia University, 62-800 Kalisz, Poland
8 shared publications - Małgorzata Mizgier
Akademia Wychowania Fizycznego im. Eugeniusza Piaseckiego w Poznaniu,Poznan,Poland; Department of Sports Dietetics,Chair of Dietetics, Faculty of Health Sciences, Poznan University of Physical Education,Poznań,Poland; Department of Sports Dietetics, Department of Dietetics, Faculty of Health Sciences,University School of Physical Education in Poznan,Poznan,Poland, Poland
8 shared publications - Katarzyna Plagens-Rotman
Center for Pediatric, Adolescent Gynecology and Sexology, Division of Gynecology, Department of Gynecology, Poznan University of Medical Sciences, 61-701 Poznan, Poland
7 shared publications - Agata Puszcz
Poznan University of Medical Sciences, Poznan, Poland, Poland
6 shared publications - Jakub Mroczyk
Poznan University of Medical Sciences,Poznan,Poland, Poland
5 shared publications
Latest Publications
- Open Access
- 11 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7046
Premenstrual Disorders in Adolescents: An Interdisciplinary Perspective
Background: Premenstrual disorders (PMDs), including premenstrual syndrome and premenstrual dysphoric disorder, are common conditions that may substantially affect adolescents’ physical and psychological well-being. However, their presentation and management during adolescence are complicated by reproductive-axis maturation, overlap with other medical conditions, and limited adolescent-specific evidence. This review aimed to provide an interdisciplinary perspective on PMDs in adolescents, integrating biological, psychological, developmental, clinical, and sociocultural aspects. Methods: A structured narrative review was conducted. Publications addressing the neuroendocrine and developmental mechanisms, clinical manifestations, psychosocial consequences, diagnosis, and treatment of PMDs were considered, with adolescent-specific evidence prioritized where available. Results: Current evidence suggests that PMDs are associated with altered sensitivity to physiological ovarian steroid fluctuations and their neuroactive effects rather than abnormal circulating hormone concentrations alone. In adolescents, PMDs may present with diverse somatic, affective, cognitive, and behavioral symptoms and are associated with impaired quality of life, school functioning, interpersonal relationships, and psychological well-being. Diagnostic assessment remains challenging because symptoms may overlap with normal pubertal changes and psychiatric disorders. Prospective monitoring of symptom cyclicity and functional impairment is therefore essential. Pharmacological treatments, particularly selective serotonin reuptake inhibitors and selected combined oral contraceptives, represent important therapeutic options, while psychological, lifestyle, physical activity, and physiotherapeutic interventions may provide additional benefits. However, most treatment evidence is derived from adult populations. Conclusions: PMDs in adolescents should be conceptualized as multidimensional conditions requiring an interdisciplinary approach integrating gynecological, psychiatric, psychological, endocrinological, primary care, and lifestyle perspectives. Greater recognition and developmentally appropriate assessment may facilitate earlier diagnosis and individualized management. Further prospective, adolescent-specific research is needed to clarify the biological and psychosocial determinants of PMDs and establish evidence-based strategies for their multidisciplinary management.
- 11 September 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (18) , 7046
Open AccessPremenstrual Disorders in Adolescents: An Interdisciplinary Perspective
Background: Premenstrual disorders (PMDs), including premenstrual syndrome and premenstrual dysphoric disorder, are common conditions that may substantially affect adolescents’ physical and psychological well-being. However, their presentation and management during adolescence are complicated by reproductive-axis maturation, overlap with other medical conditions, and limited adolescent-specific evidence. This review aimed to provide an interdisciplinary perspective on PMDs in adolescents, integrating biological, psychological, developmental, clinical, and sociocultural aspects. Methods: A structured narrative review was conducted. Publications addressing the neuroendocrine and developmental mechanisms, clinical manifestations, psychosocial consequences, diagnosis, and treatment of PMDs were considered, with adolescent-specific evidence prioritized where available. Results: Current evidence suggests that PMDs are associated with altered sensitivity to physiological ovarian steroid fluctuations and their neuroactive effects rather than abnormal circulating hormone concentrations alone. In adolescents, PMDs may present with diverse somatic, affective, cognitive, and behavioral symptoms and are associated with impaired quality of life, school functioning, interpersonal relationships, and psychological well-being. Diagnostic assessment remains challenging because symptoms may overlap with normal pubertal changes and psychiatric disorders. Prospective monitoring of symptom cyclicity and functional impairment is therefore essential. Pharmacological treatments, particularly selective serotonin reuptake inhibitors and selected combined oral contraceptives, represent important therapeutic options, while psychological, lifestyle, physical activity, and physiotherapeutic interventions may provide additional benefits. However, most treatment evidence is derived from adult populations. Conclusions: PMDs in adolescents should be conceptualized as multidimensional conditions requiring an interdisciplinary approach integrating gynecological, psychiatric, psychological, endocrinological, primary care, and lifestyle perspectives. Greater recognition and developmentally appropriate assessment may facilitate earlier diagnosis and individualized management. Further prospective, adolescent-specific research is needed to clarify the biological and psychosocial determinants of PMDs and establish evidence-based strategies for their multidisciplinary management.
- Open Access
- 30 July 2026
- Published by MDPI AG in Preprints.org
Analysis of Selected Factors Associated with Pelvic Organ Prolapse and Stress Urinary Incontinence—A Cross‐Sectional Study
Background: Pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are common pelvic floor disorders with multifactorial etiology. This study aimed to identify demographic, anthropometric, and obstetric factors associated with POP and SUI. Methods: A retrospective cross-sectional study was conducted among 5,477 women attending a tertiary urogynecological outpatient clinic between 2016 and 2025. The study group included 4,333 women diagnosed with POP or SUI, while 1,144 women with other gynecological conditions served as controls. Associations between age, body mass index (BMI), smoking, and obstetric history were evaluated using multivariable logistic regression and the U-Smile predictive method. Results: Increasing age was independently associated with a higher risk of pelvic floor disorders (OR = 1.02; 95% CI: 1.01–1.02; p < 0.0001). Overweight was associated with a reduced likelihood of POP/SUI compared with normal BMI (OR = 0.85; 95% CI: 0.73–1.00; p = 0.0444). Each additional full-term pregnancy was associated with a 35% reduction in the odds of pelvic floor disorders (OR = 0.65; 95% CI: 0.60–0.69; p < 0.0001). Underweight, obesity, preterm birth, miscarriage, and smoking were not independent predictors. Conclusions: Age, overweight status, and the number of full-term pregnancies were the strongest independent predictors of POP and SUI. Further studies are needed to clarify the unexpected protective associations observed for overweight and term pregnancies.
- 30 July 2026
- Published by MDPI AG in Preprints.org
Open AccessAnalysis of Selected Factors Associated with Pelvic Organ Prolapse and Stress Urinary Incontinence—A Cross‐Sectional Study
Background: Pelvic organ prolapse (POP) and stress urinary incontinence (SUI) are common pelvic floor disorders with multifactorial etiology. This study aimed to identify demographic, anthropometric, and obstetric factors associated with POP and SUI. Methods: A retrospective cross-sectional study was conducted among 5,477 women attending a tertiary urogynecological outpatient clinic between 2016 and 2025. The study group included 4,333 women diagnosed with POP or SUI, while 1,144 women with other gynecological conditions served as controls. Associations between age, body mass index (BMI), smoking, and obstetric history were evaluated using multivariable logistic regression and the U-Smile predictive method. Results: Increasing age was independently associated with a higher risk of pelvic floor disorders (OR = 1.02; 95% CI: 1.01–1.02; p < 0.0001). Overweight was associated with a reduced likelihood of POP/SUI compared with normal BMI (OR = 0.85; 95% CI: 0.73–1.00; p = 0.0444). Each additional full-term pregnancy was associated with a 35% reduction in the odds of pelvic floor disorders (OR = 0.65; 95% CI: 0.60–0.69; p < 0.0001). Underweight, obesity, preterm birth, miscarriage, and smoking were not independent predictors. Conclusions: Age, overweight status, and the number of full-term pregnancies were the strongest independent predictors of POP and SUI. Further studies are needed to clarify the unexpected protective associations observed for overweight and term pregnancies.
- Open Access
- 30 March 2026
- Published by MDPI AG in Preprints.org
The Association Between Female Sexual Dysfunction and Premenstrual Syndrome: Characteristics, Epidemiology and Treatment
Introduction: Premenstrual syndrome (PMS) and its more severe form - premenstrual dysphoric disorder (PMDD) constitute a significant health problem among women of reproductive age. These disorders include emotional, physical, and behavioral symptoms that occur in the late luteal phase and disappear with the onset of menstrual bleeding. Objective: The aim of the study was to present the symptomatology of PMS and PMDD, their epidemiology, pathogenesis and treatment, and to discuss their comorbidity with female sexual dysfunctions (FSD) and sexual pain disorders. Material and Methods: Five independent researchers conducted a review of the literature from the last ten years using the following databases: PubMed, Web of Science, and Google Scholar, employing the keywords “pms”, “pmdd” together with: “sexual dysfunction” and “sexology”. Results: PMS and PMDD are associated with an increased risk of sexual dysfunctions such as: hypolibidemia, anorgasmia and dyspareunia. The comorbidity is presumably due to shared hormonal predictors, dysregulation of the serotonergic system and psychosocial factors. Treatment includes a multidisciplinary approach, including pharmacotherapy, dietary interventions, and physiotherapeutic methods. Conclusions: PMS and PMDD may significantly affect women’s psychosexual functioning. Early diagnosis and comprehensive, interdisciplinary treatment may improve patients’ quality of life and reduce the negative health consequences of these disorders.
- 30 March 2026
- Published by MDPI AG in Preprints.org
Open AccessThe Association Between Female Sexual Dysfunction and Premenstrual Syndrome: Characteristics, Epidemiology and Treatment
Introduction: Premenstrual syndrome (PMS) and its more severe form - premenstrual dysphoric disorder (PMDD) constitute a significant health problem among women of reproductive age. These disorders include emotional, physical, and behavioral symptoms that occur in the late luteal phase and disappear with the onset of menstrual bleeding. Objective: The aim of the study was to present the symptomatology of PMS and PMDD, their epidemiology, pathogenesis and treatment, and to discuss their comorbidity with female sexual dysfunctions (FSD) and sexual pain disorders. Material and Methods: Five independent researchers conducted a review of the literature from the last ten years using the following databases: PubMed, Web of Science, and Google Scholar, employing the keywords “pms”, “pmdd” together with: “sexual dysfunction” and “sexology”. Results: PMS and PMDD are associated with an increased risk of sexual dysfunctions such as: hypolibidemia, anorgasmia and dyspareunia. The comorbidity is presumably due to shared hormonal predictors, dysregulation of the serotonergic system and psychosocial factors. Treatment includes a multidisciplinary approach, including pharmacotherapy, dietary interventions, and physiotherapeutic methods. Conclusions: PMS and PMDD may significantly affect women’s psychosexual functioning. Early diagnosis and comprehensive, interdisciplinary treatment may improve patients’ quality of life and reduce the negative health consequences of these disorders.
- Open Access
- 4 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1220
Human Sexual Development in the Somatic and Psychosexual Context
Human sexual development begins in the prenatal period and continues throughout life, shaped by both biological and psychosocial factors. Somatic development leads to reproductive maturity through several stages regulated by the hypothalamic–pituitary–gonadal axis. Psychosexual development, described in classical theories such as Freud’s and in contemporary models, emphasizes the development of gender identity and sexual behaviors from infancy through early and middle childhood into adolescence, a period characterized by the integration of sexual and emotional components. This developmental trajectory evolves from a biologically driven process into a conscious, socially shaped phenomenon through concretization, mentalization, and socialization. To synthesize current knowledge, this paper is based on a literature review conducted across multiple databases, with studies selected and evaluated for relevance to both somatic and psychosexual development. Understanding the dynamics of these processes is essential for clinical practice, sexual education, and health prevention. It emphasizes integrated clinical practices that employ a multidisciplinary approach, incorporating both medical treatment and psychological support, particularly in the care of children and adolescents with disorders of sexual development. This article presents a comprehensive overview of human sexual development from the prenatal period through adolescence, considering its somatic and psychosexual aspects.
- 4 February 2026
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (3) , 1220
Open AccessHuman Sexual Development in the Somatic and Psychosexual Context
Human sexual development begins in the prenatal period and continues throughout life, shaped by both biological and psychosocial factors. Somatic development leads to reproductive maturity through several stages regulated by the hypothalamic–pituitary–gonadal axis. Psychosexual development, described in classical theories such as Freud’s and in contemporary models, emphasizes the development of gender identity and sexual behaviors from infancy through early and middle childhood into adolescence, a period characterized by the integration of sexual and emotional components. This developmental trajectory evolves from a biologically driven process into a conscious, socially shaped phenomenon through concretization, mentalization, and socialization. To synthesize current knowledge, this paper is based on a literature review conducted across multiple databases, with studies selected and evaluated for relevance to both somatic and psychosexual development. Understanding the dynamics of these processes is essential for clinical practice, sexual education, and health prevention. It emphasizes integrated clinical practices that employ a multidisciplinary approach, incorporating both medical treatment and psychological support, particularly in the care of children and adolescents with disorders of sexual development. This article presents a comprehensive overview of human sexual development from the prenatal period through adolescence, considering its somatic and psychosexual aspects.
- Open Access
- 31 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 307
Lifestyle and Selected Issues Related to Sexual Health: The Importance of Specialist Care in Balneology, Dietetics, and Physiotherapy
Background/Objectives: Sexual health is shaped by lifestyle factors alongside biomedical determinants. This review synthesises evidence on physiotherapy, balneology/peloidotherapy, and diet therapy as preventive and therapeutic adjuncts for female sexual dysfunctions and related gynaecological conditions. Methods: A structured narrative review of PubMed and Google Scholar (June–July 2025) was conducted by three independent reviewers using predefined keywords in English and Polish. Case reports, preprints, and studies before 2015 were excluded. From 7322 records, 47 studies met the inclusion criteria for qualitative synthesis. Results: Physiotherapy—particularly pelvic floor muscle training, multimodal manual therapy, neuromuscular electrical stimulation (including PTNS), magnetostimulation, short-wave diathermy, and capacitive–resistive monopolar radiofrequency—was consistently associated with reductions in dyspareunia, chronic pelvic pain, and urinary symptoms, with parallel improvements in sexual function and quality of life. Balneological procedures (brine baths/irrigations, crenotherapy, selected radon/sulphide/iodine–bromine applications) and peloidotherapy demonstrated analgesic, anti-inflammatory, and perfusion-enhancing effects, with signals of benefit in vulvodynia, endometriosis, and infertility support. Dietary measures—higher fruit intake (notably citrus), adequate vitamin D, targeted omega-3 use in PCOS, a Mediterranean dietary pattern, and prudent red-meat limitation—were associated with favourable endocrine–metabolic profiles and, in selected contexts, reduced disease risk. Conclusions: Integrating lifestyle–medicine modalities with standard care may meaningfully prevent and manage female sexual dysfunctions by addressing pain, perfusion, neuromuscular control, and endocrine–metabolic drivers. Implementation frameworks and high-quality trials are warranted to refine indications, dosing, and long-term effectiveness.
- 31 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 15 (1) , 307
Open AccessLifestyle and Selected Issues Related to Sexual Health: The Importance of Specialist Care in Balneology, Dietetics, and Physiotherapy
Background/Objectives: Sexual health is shaped by lifestyle factors alongside biomedical determinants. This review synthesises evidence on physiotherapy, balneology/peloidotherapy, and diet therapy as preventive and therapeutic adjuncts for female sexual dysfunctions and related gynaecological conditions. Methods: A structured narrative review of PubMed and Google Scholar (June–July 2025) was conducted by three independent reviewers using predefined keywords in English and Polish. Case reports, preprints, and studies before 2015 were excluded. From 7322 records, 47 studies met the inclusion criteria for qualitative synthesis. Results: Physiotherapy—particularly pelvic floor muscle training, multimodal manual therapy, neuromuscular electrical stimulation (including PTNS), magnetostimulation, short-wave diathermy, and capacitive–resistive monopolar radiofrequency—was consistently associated with reductions in dyspareunia, chronic pelvic pain, and urinary symptoms, with parallel improvements in sexual function and quality of life. Balneological procedures (brine baths/irrigations, crenotherapy, selected radon/sulphide/iodine–bromine applications) and peloidotherapy demonstrated analgesic, anti-inflammatory, and perfusion-enhancing effects, with signals of benefit in vulvodynia, endometriosis, and infertility support. Dietary measures—higher fruit intake (notably citrus), adequate vitamin D, targeted omega-3 use in PCOS, a Mediterranean dietary pattern, and prudent red-meat limitation—were associated with favourable endocrine–metabolic profiles and, in selected contexts, reduced disease risk. Conclusions: Integrating lifestyle–medicine modalities with standard care may meaningfully prevent and manage female sexual dysfunctions by addressing pain, perfusion, neuromuscular control, and endocrine–metabolic drivers. Implementation frameworks and high-quality trials are warranted to refine indications, dosing, and long-term effectiveness.
- Open Access
- 15 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (24) , 8863
The Role of Prophylaxis and Dietotherapy in Gynecology in the Context of the Interdisciplinary Nature of Genital Discomfort—A Pilot Report
Background/Objectives: Genital discomfort, manifested by vulvar itching and burning, is a frequent complaint among women of all ages and has multifactorial origins—including dermatoses, infections, allergies, and hormonal disorders. The study aimed to determine whether selected medical history factors—age, obstetric history, and body mass index (BMI)—influence the frequency of genital discomfort as a reason for gynecological consultation. Methods: A pilot study included 288 female patients aged 11–91 years who presented to outpatient gynecological clinics between September 2018 and February 2025 with symptoms of vulvar itching and genital discomfort. Qualitative data were expressed as numbers and percentages, and age was described using mean, median, quartiles, and range. Associations between categorical variables were assessed using Pearson’s chi-square test, with statistical significance set at p < 0.05. Results: The mean age of patients was 47.4 ± 20.3 years. Most were diagnosed with ICD-10 code N90 (82.6%), while 17.4% had N76. Genital discomfort was most frequently reported by women aged 41–50 years (p < 0.0001). Comorbidities (p < 0.0001) and obstetric history (p < 0.0001) significantly influenced the occurrence of genital discomfort, which was more prevalent among women with chronic conditions and those who had been pregnant. No significant associations were found with BMI (p = 0.2353) or menopausal status (p = 0.3458). Conclusions: Genital discomfort is a common and multifactorial condition requiring an interdisciplinary diagnostic and therapeutic approach. Collaboration among gynecologists, dermatologists, endocrinologists, and dietitians is crucial for effective management and prevention.
- 15 December 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (24) , 8863
Open AccessThe Role of Prophylaxis and Dietotherapy in Gynecology in the Context of the Interdisciplinary Nature of Genital Discomfort—A Pilot Report
Background/Objectives: Genital discomfort, manifested by vulvar itching and burning, is a frequent complaint among women of all ages and has multifactorial origins—including dermatoses, infections, allergies, and hormonal disorders. The study aimed to determine whether selected medical history factors—age, obstetric history, and body mass index (BMI)—influence the frequency of genital discomfort as a reason for gynecological consultation. Methods: A pilot study included 288 female patients aged 11–91 years who presented to outpatient gynecological clinics between September 2018 and February 2025 with symptoms of vulvar itching and genital discomfort. Qualitative data were expressed as numbers and percentages, and age was described using mean, median, quartiles, and range. Associations between categorical variables were assessed using Pearson’s chi-square test, with statistical significance set at p < 0.05. Results: The mean age of patients was 47.4 ± 20.3 years. Most were diagnosed with ICD-10 code N90 (82.6%), while 17.4% had N76. Genital discomfort was most frequently reported by women aged 41–50 years (p < 0.0001). Comorbidities (p < 0.0001) and obstetric history (p < 0.0001) significantly influenced the occurrence of genital discomfort, which was more prevalent among women with chronic conditions and those who had been pregnant. No significant associations were found with BMI (p = 0.2353) or menopausal status (p = 0.3458). Conclusions: Genital discomfort is a common and multifactorial condition requiring an interdisciplinary diagnostic and therapeutic approach. Collaboration among gynecologists, dermatologists, endocrinologists, and dietitians is crucial for effective management and prevention.
- Open Access
- 14 November 2025
- Published by MDPI AG in Preprints.org
Lifestyle and Selected Issues Related to Sexual Health: The Importance of Specialist Care in Balneology, Dietetics, and Physiotherapy
Background/Objectives: Sexual health is shaped by lifestyle factors alongside biomedical determinants. This review synthesises evidence on physiotherapy, balneology/peloidotherapy and diet therapy as preventive and therapeutic adjuncts for female sexual dysfunctions and related gynaecological conditions. Methods: A structured narrative review of PubMed and Google Scholar (June–July 2025) was conducted by three independent reviewers using predefined keywords in English and Polish. Case reports, preprints and studies before 2015 were excluded. From 7322 records, 47 studies met inclusion criteria for qualitative synthesis. Results: Physiotherapy—particularly pelvic floor muscle training, multimodal manual therapy, neuromuscular electrical stimulation (including PTNS), magnetostimulation, short-wave diathermy and capacitive–resistive monopolar radiofrequency—was consistently associated with reductions in dyspareunia, chronic pelvic pain and urinary symptoms, with parallel improvements in sexual function and quality of life. Balneological procedures (brine baths/irrigations, crenotherapy, selected radon/sulphide/iodine–bromine applications) and peloidotherapy demonstrated analgesic, anti-inflammatory and perfusion-enhancing effects, with signals of benefit in vulvodynia, endometriosis and infertility support. Dietary measures—higher fruit intake (notably citrus), adequate vitamin D, targeted omega-3 use in PCOS, Mediterranean dietary pattern and prudent red-meat limitation—were associated with favourable endocrine–metabolic profiles and, in selected contexts, reduced disease risk. Conclusions: Integrating lifestyle-medicine modalities with standard care may meaningfully prevent and manage female sexual dysfunctions by addressing pain, perfusion, neuromuscular control and endocrine–metabolic drivers. Implementation frameworks and high-quality trials are warranted to refine indications, dosing and long-term effectiveness.
- 14 November 2025
- Published by MDPI AG in Preprints.org
Open AccessLifestyle and Selected Issues Related to Sexual Health: The Importance of Specialist Care in Balneology, Dietetics, and Physiotherapy
Background/Objectives: Sexual health is shaped by lifestyle factors alongside biomedical determinants. This review synthesises evidence on physiotherapy, balneology/peloidotherapy and diet therapy as preventive and therapeutic adjuncts for female sexual dysfunctions and related gynaecological conditions. Methods: A structured narrative review of PubMed and Google Scholar (June–July 2025) was conducted by three independent reviewers using predefined keywords in English and Polish. Case reports, preprints and studies before 2015 were excluded. From 7322 records, 47 studies met inclusion criteria for qualitative synthesis. Results: Physiotherapy—particularly pelvic floor muscle training, multimodal manual therapy, neuromuscular electrical stimulation (including PTNS), magnetostimulation, short-wave diathermy and capacitive–resistive monopolar radiofrequency—was consistently associated with reductions in dyspareunia, chronic pelvic pain and urinary symptoms, with parallel improvements in sexual function and quality of life. Balneological procedures (brine baths/irrigations, crenotherapy, selected radon/sulphide/iodine–bromine applications) and peloidotherapy demonstrated analgesic, anti-inflammatory and perfusion-enhancing effects, with signals of benefit in vulvodynia, endometriosis and infertility support. Dietary measures—higher fruit intake (notably citrus), adequate vitamin D, targeted omega-3 use in PCOS, Mediterranean dietary pattern and prudent red-meat limitation—were associated with favourable endocrine–metabolic profiles and, in selected contexts, reduced disease risk. Conclusions: Integrating lifestyle-medicine modalities with standard care may meaningfully prevent and manage female sexual dysfunctions by addressing pain, perfusion, neuromuscular control and endocrine–metabolic drivers. Implementation frameworks and high-quality trials are warranted to refine indications, dosing and long-term effectiveness.
- Open Access
- 4 November 2025
- Published by MDPI AG in Preprints.org
The Role of Prophylaxis and Dietotherapy in Gynecology in the Context of the Interdisciplinary Nature of Genital Discomfort – A Pilot Report
Background/Objectives: Genital discomfort, manifested by vulvar itching and burning, is a frequent complaint among women of all ages and has multifactorial origins—including dermatoses, infections, allergies, and hormonal disorders. The study aimed to determine whether selected medical history factors—age, obstetric history, and body mass index (BMI)—influence the frequency of genital discomfort as a reason for gynecological consultation. Methods: A pilot study included 288 female patients aged 11–91 years who presented to outpatient gynecological clinics between September 2018 and February 2025 with symptoms of vulvar itching and genital discomfort. Qualitative data were expressed as numbers and percentages, and age was described using mean, median, quartiles, and range. Associations between categorical variables were assessed using Pearson’s chi-square test, with statistical significance set at p < 0.05. Results: The mean age of patients was 47.4 ± 20.3 years. Most were diagnosed with ICD-10 code N90 (82.6%), while 17.4% had N76. Genital discomfort was most frequently reported by women aged 41–50 years (p < 0.0001). Comorbidities (p < 0.0001) and obstetric history (p < 0.0001) significantly influenced the occurrence of genital discomfort, which was more prevalent among women with chronic conditions and those who had been pregnant. No significant associations were found with BMI (p = 0.2353) or menopausal status (p = 0.3458). Conclusions: Genital discomfort is a common and multifactorial condition requiring an interdisciplinary diagnostic and therapeutic approach. Collaboration among gynecologists, dermatologists, endocrinologists, and dietitians is crucial for effective management and prevention.
- 4 November 2025
- Published by MDPI AG in Preprints.org
Open AccessThe Role of Prophylaxis and Dietotherapy in Gynecology in the Context of the Interdisciplinary Nature of Genital Discomfort – A Pilot Report
Background/Objectives: Genital discomfort, manifested by vulvar itching and burning, is a frequent complaint among women of all ages and has multifactorial origins—including dermatoses, infections, allergies, and hormonal disorders. The study aimed to determine whether selected medical history factors—age, obstetric history, and body mass index (BMI)—influence the frequency of genital discomfort as a reason for gynecological consultation. Methods: A pilot study included 288 female patients aged 11–91 years who presented to outpatient gynecological clinics between September 2018 and February 2025 with symptoms of vulvar itching and genital discomfort. Qualitative data were expressed as numbers and percentages, and age was described using mean, median, quartiles, and range. Associations between categorical variables were assessed using Pearson’s chi-square test, with statistical significance set at p < 0.05. Results: The mean age of patients was 47.4 ± 20.3 years. Most were diagnosed with ICD-10 code N90 (82.6%), while 17.4% had N76. Genital discomfort was most frequently reported by women aged 41–50 years (p < 0.0001). Comorbidities (p < 0.0001) and obstetric history (p < 0.0001) significantly influenced the occurrence of genital discomfort, which was more prevalent among women with chronic conditions and those who had been pregnant. No significant associations were found with BMI (p = 0.2353) or menopausal status (p = 0.3458). Conclusions: Genital discomfort is a common and multifactorial condition requiring an interdisciplinary diagnostic and therapeutic approach. Collaboration among gynecologists, dermatologists, endocrinologists, and dietitians is crucial for effective management and prevention.
- Open Access
- 4 March 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (5) , 1071
Gynecological Problems in Newborns and Infants
Pediatric-adolescent or developmental gynecology has been separated from general gynecology because of the unique issues that affect the development and anatomy of growing girls and young women. It deals with patients from the neonatal period until maturity. There are not many gynecological problems that can be diagnosed in newborns; however, some are typical of the neonatal period. This paper aims to discuss the most frequent gynecological issues in the neonatal period.
- 4 March 2021
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 10 (5) , 1071
Open AccessGynecological Problems in Newborns and Infants
Pediatric-adolescent or developmental gynecology has been separated from general gynecology because of the unique issues that affect the development and anatomy of growing girls and young women. It deals with patients from the neonatal period until maturity. There are not many gynecological problems that can be diagnosed in newborns; however, some are typical of the neonatal period. This paper aims to discuss the most frequent gynecological issues in the neonatal period.
- Open Access
- 25 September 2018
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (10) , 2901
The Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines
The major cause of ovarian cancer treatment failure in cancer patients is inherent or acquired during treatment drug resistance of cancer. Matrix Gla protein (MGP) is a secreted, non-collagenous extracellular matrix protein involved in inhibition of tissue calcification. Recently, MGP expression was related to cellular differentiation and tumor progression. A detailed MGP expression analysis in sensitive (A2780) and resistant to paclitaxel (PAC) (A2780PR) and topotecan (TOP) (A2780TR) ovarian cancer cell lines and their corresponding media was performed. MGP mRNA level (real time PCR analysis) and protein expression in cell lysates and cell culture medium (Western blot analysis) and protein expression in cancer cells (immunofluorescence analysis) and cancer patient lesions (immunohistochemistry) were determined in this study. We observed increased expression of MGP in PAC and TOP resistant cell lines at both mRNA and protein level. MGP protein was also detected in the corresponding culture media. Finally, we detected expression of MGP protein in ovarian cancer lesions from different histological type of cancer. MGP is an important factor that might contribute to cancer resistance mechanism by augmenting the interaction of cells with ECM components leading to increased resistance of ovarian cancer cells to paclitaxel and topotecan. Expression found in ovarian cancer tissue suggests its possible role in ovarian cancer pathogenesis.
- 25 September 2018
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 19 (10) , 2901
Open AccessThe Role of Matrix Gla Protein (MGP) Expression in Paclitaxel and Topotecan Resistant Ovarian Cancer Cell Lines
The major cause of ovarian cancer treatment failure in cancer patients is inherent or acquired during treatment drug resistance of cancer. Matrix Gla protein (MGP) is a secreted, non-collagenous extracellular matrix protein involved in inhibition of tissue calcification. Recently, MGP expression was related to cellular differentiation and tumor progression. A detailed MGP expression analysis in sensitive (A2780) and resistant to paclitaxel (PAC) (A2780PR) and topotecan (TOP) (A2780TR) ovarian cancer cell lines and their corresponding media was performed. MGP mRNA level (real time PCR analysis) and protein expression in cell lysates and cell culture medium (Western blot analysis) and protein expression in cancer cells (immunofluorescence analysis) and cancer patient lesions (immunohistochemistry) were determined in this study. We observed increased expression of MGP in PAC and TOP resistant cell lines at both mRNA and protein level. MGP protein was also detected in the corresponding culture media. Finally, we detected expression of MGP protein in ovarian cancer lesions from different histological type of cancer. MGP is an important factor that might contribute to cancer resistance mechanism by augmenting the interaction of cells with ECM components leading to increased resistance of ovarian cancer cells to paclitaxel and topotecan. Expression found in ovarian cancer tissue suggests its possible role in ovarian cancer pathogenesis.